Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

635 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis.
Montalban X, Gold R, Thompson AJ, Otero-Romero S, Amato MP, Chandraratna D, Clanet M, Comi G, Derfuss T, Fazekas F, Hartung HP, Havrdova E, Hemmer B, Kappos L, Liblau R, Lubetzki C, Marcus E, Miller DH, Olsson T, Pilling S, Selmaj K, Siva A, Sorensen PS, Sormani MP, Thalheim C, Wiendl H, Zipp F. Montalban X, et al. Among authors: fazekas f. Mult Scler. 2018 Feb;24(2):96-120. doi: 10.1177/1352458517751049. Epub 2018 Jan 20. Mult Scler. 2018. PMID: 29353550
Spinal-cord MRI in multiple sclerosis.
Lycklama G, Thompson A, Filippi M, Miller D, Polman C, Fazekas F, Barkhof F. Lycklama G, et al. Among authors: fazekas f. Lancet Neurol. 2003 Sep;2(9):555-62. doi: 10.1016/s1474-4422(03)00504-0. Lancet Neurol. 2003. PMID: 12941578
MRI to monitor treatment efficacy in multiple sclerosis.
Fazekas F, Soelberg-Sorensen P, Comi G, Filippi M. Fazekas F, et al. J Neuroimaging. 2007 Apr;17 Suppl 1:50S-55S. doi: 10.1111/j.1552-6569.2007.00138.x. J Neuroimaging. 2007. PMID: 17425736 Review.
Influence of interferon-beta therapy switching on neutralizing antibody titres: results from the Austrian Switch Study.
Gneiss C, Koudouovoh-Tripp PM, Ropele S, Gotwald T, Ehling R, Lutterotti A, Aichner F, Ladurner G, Eggers C, Schautzer F, Künz B, Millonig A, Aspeck E, Reindl M, Berger T, Fazekas F, Deisenhammer F. Gneiss C, et al. Among authors: fazekas f. Mult Scler. 2009 Dec;15(12):1481-8. doi: 10.1177/1352458509347153. Epub 2009 Nov 13. Mult Scler. 2009. PMID: 19965519 Clinical Trial.
Relationship between brain MRI lesion load and short-term disease evolution in non-disabling MS: a large-scale, multicentre study.
Rovaris M, Rocca MA, Barkhof F, Calabrese M, De Stefano N, Khalil M, Fazekas F, Fisniku L, Gallo P, Miller DH, Montalban X, Polman C, Rovira A, Sombekke MH, Sormani MP, Stromillo ML, Filippi M. Rovaris M, et al. Among authors: fazekas f. Mult Scler. 2011 Mar;17(3):319-26. doi: 10.1177/1352458510388824. Epub 2010 Dec 15. Mult Scler. 2011. PMID: 21159719
MRI monitoring of immunomodulation in relapse-onset multiple sclerosis trials.
Barkhof F, Simon JH, Fazekas F, Rovaris M, Kappos L, de Stefano N, Polman CH, Petkau J, Radue EW, Sormani MP, Li DK, O'Connor P, Montalban X, Miller DH, Filippi M. Barkhof F, et al. Among authors: fazekas f. Nat Rev Neurol. 2011 Dec 6;8(1):13-21. doi: 10.1038/nrneurol.2011.190. Nat Rev Neurol. 2011. PMID: 22143362 Review.
635 results